1 results
Approved WMORecruiting
This study has been transitioned to CTIS with ID 2023-503916-33-00 check the CTIS register for the current data. Primary Objective• Evaluate the efficacy of loncastuximab tesirine combined with rituximab compared to standard immunochemotherapy…